semaglutide or Novo Nordisk medicines containing Semaglutide, or Ozempic, reduces symptoms

NOT FOR HUMAN CONSUMPTION , medical, or veterinary use

N Engl J Med 2019;381:84151.ArticlePubMed 72

This prolonged retention might increase intragastric pressure and potentially promote retrograde movement of gastric contents into the esophagus, particularly in patients with pre-existing lower esophageal sphincter dysfunction or hiatal hernia

The details and characteristics of each of the individual outcome trials were published in recent reviews [25]

As semaglutide GLP-1 begins to take effect, it slows gastric emptying and alters hunger signals, but this process generally takes several days to weeks to become more noticeable